Systolic blood pressure for African-American patients dropped between one to five points when they moved to less segregated neighborhoods, according to a new study.
Browsing: Marla Paul
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
Northwestern Medicine scientists have developed a miniature female reproductive tract that could eventually change the future of research and treatment of diseases in women’s reproductive organs.
In research published in Nature Medicine, Northwestern Medicine scientists have found a molecule that stops the growth of an aggressive pediatric brain tumor for which there is no current treatment.
A novel national trial for people with no established alternative to treat their rare cancers is being co-led by Northwestern Medicine investigators, who helped conceive of and develop the project.
Northwestern Medicine scientists have identified a molecular therapy to prevent the growth of a rare pediatric leukemia.
Feinberg’s PhD in healthcare quality and patient safety program aims to prevent 440,000 deaths each year in the United States caused by medical errors.
New research from Northwestern Medicine and the Rehabilitation Institute of Chicago scientists has identified the brain region responsible for the placebo response to pain.
Northwestern Medicine scientists have discovered circadian clocks in muscle tissue that control the muscle’s metabolic response and energy efficiency depending on the time of day.
A new pathway in the brain can be manipulated to alleviate depression, offering a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.